Seelaus Asset Management’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-19,150
Closed -$264K 211
2026
Q1
$264K Buy
19,150
+300
+2% +$4.52K 0.19% 152
2025
Q4
$340K Buy
18,850
+2,000
+12% +$35.9K 0.27% 104
2025
Q3
$312K Buy
16,850
+1,600
+10% +$25.1K 0.25% 118
2025
Q2
$244K Buy
+15,250
New +$272K 0.22% 138
2024
Q3
Sell
-10,150
Closed -$121K 177
2024
Q2
$121K Buy
+10,150
New +$113K 0.12% 162

Other funds holding CLBT

Seelaus Asset Management's CLBT Position: Q2 2026 in Review

Seelaus Asset Management sold out of Cellebrite (CLBT) in Q2 2026, closing a stake of 19,150 shares — an estimated $264K sold.

Seelaus Asset Management first reported a position in CLBT in Q2 2024 and held it in 5 quarters. The position peaked at $340K in Q4 2025. 35 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Seelaus Asset Management reported no remaining Cellebrite position as of Q2 2026 after selling out during the quarter.
  • Seelaus Asset Management sold 19,150 Cellebrite shares in Q2 2026, an estimated $264K.
  • Seelaus Asset Management first reported a position in Cellebrite in Q2 2024 and held it in 5 quarters.
  • Seelaus Asset Management's Cellebrite position peaked at $340K in Q4 2025.
  • 35 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Seelaus Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.